BioSpace News Archive

Pharm Country

Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 02, 2022

IVERIC bio, Inc. reported that on November 1, 2022, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive employees.

November 2, 2022
·
2 min read
Business

Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has partnered with Us2.ai , the developer of AI software that fully automates a complete echocardiography, or heart ultrasound, report.

November 2, 2022
·
3 min read
Business

Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Officer to Spearhead Iomab-B Commercialization

Actinium Pharmaceuticals, Inc. today announced the appointment of Caroline Yarbrough as Chief Commercial Officer.

November 2, 2022
·
9 min read
Business

NTT Research Develops Closed-Loop Control of Innervated Tissue

NTT Research, Inc., a division of NTT (TYO:9432), today announced that the collaboration between its Medical & Health Informatics (MEI) Lab and the Technical University of Munich (TUM) has produced a novel technique for closed-loop control of innervated tissue of a live insect.

November 2, 2022
·
5 min read
Deals

OrsoBio Announces Acquisition of LXR Inverse Agonist Program for Treatment of Severe Dyslipidemias from Phenex Pharmaceuticals

OrsoBio, Inc. today announced its acquisition of assets relating to the Liver X Receptor (LXR) inverse agonist program from Phenex Pharmaceuticals, including lead candidate TLC-2716 and associated intellectual property.

November 2, 2022
·
5 min read
Business

CorMedix Inc. to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10

CorMedix Inc. today announced that it will report its financial results for the third quarter ended September 30, 2022, before the market open on Thursday, November 10, 2022, and will host a corporate update conference call at 8:30am Eastern Time.

November 2, 2022
·
2 min read
Biotech Bay

ProSomnus® Announces FDA 510(k) Clearance for ProSomnus EVO™ [PH] Sleep and Snore Device

ProSomnus (“the Company”), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the ProSomnus EVO™ [PH] Sleep and Snore Device.

November 2, 2022
·
10 min read
Business

Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma’s Medication for Treating Depression in Cancer Patients

ABVC Biopharma, Inc. today announced that the Cedars-Sinai Medical Center (CSMC, West Hollywood CA) Institutional Review Board (IRB) has approved their institution joining the Phase I study of ABV-1601 for treating depression in cancer patients.

November 2, 2022
·
3 min read
Business

Evoke Pharma to Report Third Quarter Results on November 9, 2022

Evoke Pharma, Inc. today announced that the Company is scheduled to release its third quarter on Wednesday, November 9, 2022, after the market closes.

November 2, 2022
·
3 min read
Deals

Precision Optics Announces Updated Implementation Date of 1-for-3 Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq

Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) announced today that the planned 1-for-3 reverse split of its common stock became effective after the close of business on Tuesday, November 1, 2022 (the “Effective Time”).

November 2, 2022
·
4 min read